NCT05047094 2026-04-06
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
Alpha Tau Medical LTD.
Phase NA Recruiting
Clinical Trials
4 trialsNCT07343596 2026-03-24
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
University of Wisconsin, Madison
Phase NA Recruiting
NCT07422779 2026-02-20
MAK
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT03769129 2024-06-25
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting